Evidence map›Paper›PMID 37648378›Full record

ArticleBMJ open2023

Recruiting historically under-represented individuals into Project ECHO Diabetes: using barrier analysis to understand disparities in clinical research in the USA.

Ananta Addala, Melanie Hechavarria, Lauren Figg, Xanadu Roque, Stephanie L Filipp, Claudia Anez-Zabala, Rayhan Lal, Matthew J Gurka, Michael J Haller, David M Maahs and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. COVID-19 impacts and inequities among underserved communities with diabetes.Journal of clinical & translational endocrinology · 2024
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Ananta AddalaDepartment of Pediatrics, Division of Pediatric Endocrinology, Stanford University, Stanford, California, USA aaddala@stanford.edu.ORCID 0000-0002-0508-4309
Melanie HechavarriaDepartment of Pediatrics, University of Florida, Gainesville, Florida, USA.
Lauren FiggDepartment of Pediatrics, Division of Pediatric Endocrinology, Stanford University, Stanford, California, USA.
Xanadu RoqueDepartment of Pediatrics, University of Florida, Gainesville, Florida, USA.
Stephanie L FilippDepartment of Pediatrics, University of Florida, Gainesville, Florida, USA.
Claudia Anez-ZabalaDepartment of Pediatrics, University of Florida, Gainesville, Florida, USA.
Rayhan LalDepartment of Pediatrics, Stanford Diabetes Research Center, Stanford, California, USA.
Matthew J GurkaDepartment of Pediatrics, University of Florida, Gainesville, Florida, USA.
Michael J HallerDepartment of Pediatrics, University of Florida, Gainesville, Florida, USA.
David M MaahsDepartment of Pediatrics, Division of Pediatric Endocrinology, Stanford University, Stanford, California, USA.
Ashby F WalkerHealth Services Research Management and Policy, University of Florida, Gainesville, Florida, USA.ORCID 0000-0002-7554-2344
University of Florida · USStanford University · US

Funding

Stanford Islet Research CoreP30DK116074 · NIDDK · STANFORD UNIVERSITY · PI Holden T. Maecker · 2017 to 2026
$19.5M
Reducing Disparities in Pediatric Diabetes: Building the Evidence Base to Inform Effective Diabetes Technology Interventions in Underrepresented MinoritiesK23DK131342 · NIDDK · STANFORD UNIVERSITY · PI ADDALA, ANANTA · 2022 to 2025
$970k
The Optimal Pathway to Implanted Autonomous Insulin DeliveryK23DK122017 · NIDDK · STANFORD UNIVERSITY · PI LAL, RAYHAN · 2020 to 2024
$958k
NIDDK NIH HHS K23 DK122017NIDDK NIH HHS K23 DK131342NIDDK NIH HHS P30 DK116074
6 · The paper itself

Abstract

objectivesIndividuals under-recruited in diabetes research studies include those not seen at endocrinology centres and those from rural, low socioeconomic and/or under-represented racial/ethnic groups. The purpose of this descriptive analysis is to detail recruitment and retention efforts of Project ECHO Diabetes clinical sites affiliated with Stanford University and University of Florida.

designProspective collection of participant engagement and qualitative analysis of barriers and facilitators of research engagement within Project ECHO Diabetes, a virtual tele-education programme for healthcare providers in the management of individuals with insulin-requiring diabetes.

settingData were collected at the patient level, provider level and clinic level between 1 May 2021 and 31 July 2022.

participantsParticipants and study personnel were recruited from 33 Project ECHO Diabetes sites in California and Florida. OUTCOMES: We report study completion rates for participants recruited into 33 Project ECHO Diabetes sites. Using barrier analysis, a methodology designed for the real-time assessment of interventions and system processes to identify barriers and facilitators, study personnel identified significant barriers to recruitment and retention and mapped them to actionable solutions.

resultsIn total, 872 participants (California n=495, Florida n=377) were recruited with differing recruitment rates by site (California=52.7%, Florida=21.5%). Barrier analysis identified lack of trust, unreliable contact information, communication issues and institutional review board (IRB) requirements as key recruitment barriers. Culturally congruent staff, community health centre (CHC) support, adequate funding and consent process flexibility were solutions to address recruitment challenges. Barriers to retention were inconsistent postal access, haemoglobin A1c kit collection challenges, COVID-19 pandemic and broadband/connectivity issues. Additional funding supporting research staff and analogue communication methods were identified as solutions address barriers to retention.

conclusionsFunded partnerships with CHCs, trusted by their local communities, were key in our recruitment and retention strategies. IRB consent process flexibility reduced barriers to recruitment. Recruiting historically under-represented populations is feasible with funding aimed to address structural barriers to research participation.

Indexed as

COVID-19Diabetes MellitusFloridaHumansPandemicsProspective StudiesClinical TrialDIABETES & ENDOCRINOLOGYHealth EquityPatient ParticipationSTATISTICS & RESEARCH METHODS

Identifiers

PMID37648378
PMCPMC10471869
OpenAlexW4386295951

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.